Eriksson, J. K., Karlsson, J. A., Bratt, J., Petersson, I. F., van Vollenhoven, R. F., Ernestam, S., . . . Neovius, M. (2015). Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial. Ann Rheum Dis.

Eriksson, Jonas K., Johan A. Karlsson, Johan Bratt, Ingemar F. Petersson, Ronald F. van Vollenhoven, Sofia Ernestam, Pierre Geborek, and Martin Neovius. "Cost-effectiveness of Infliximab Versus Conventional Combination Treatment in Methotrexate-refractory Early Rheumatoid Arthritis: 2-year Results of the Register-enriched Randomised Controlled SWEFOT Trial." Ann Rheum Dis 2015.

Eriksson, Jonas K., et al. "Cost-effectiveness of Infliximab Versus Conventional Combination Treatment in Methotrexate-refractory Early Rheumatoid Arthritis: 2-year Results of the Register-enriched Randomised Controlled SWEFOT Trial." Ann Rheum Dis 2015.